• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类消退性黑色素瘤肿瘤浸润淋巴细胞中T细胞受体变异性分析。原位T细胞克隆性扩增的证据。

Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.

作者信息

Ferradini L, Mackensen A, Genevée C, Bosq J, Duvillard P, Avril M F, Hercend T

机构信息

Laboratoire d'Hémato-Immunologie, Institut National de la Santé et de la Recherche Médicale U333, Villejuif, France.

出版信息

J Clin Invest. 1993 Mar;91(3):1183-90. doi: 10.1172/JCI116278.

DOI:10.1172/JCI116278
PMID:8450047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC288075/
Abstract

Malignant melanomas are often infiltrated by T lymphocytes. It is postulated that the presence of tumor-infiltrating lymphocytes (TIL) reflects ongoing immune responses against transformed cells. Such "responses" appear generally inefficient with the potential exception of infrequent clinical situations characterized by spontaneous tumor regression. We have characterized here the molecular structure of the T cell receptor beta chain expressed by TILs in a case of regressive melanoma. Advantage was taken of the PCR technology to study T lymphocytes directly without cell culture. Experimentally validated V beta subfamily specific primers were used to evaluate the V beta usage in TILs and control samples. Our results reveal that clonal T cell populations, precisely defined by their V-D-J junctional sequences, are amplified at the tumor site. The existence of such local antigen-driven selections support the hypothesis that antitumor responses may indeed take place in regressive melanoma.

摘要

恶性黑色素瘤常被T淋巴细胞浸润。据推测,肿瘤浸润淋巴细胞(TIL)的存在反映了针对转化细胞的持续免疫反应。除了以肿瘤自发消退为特征的罕见临床情况外,这种“反应”通常效率低下。我们在此描述了一例消退性黑色素瘤中TIL表达的T细胞受体β链的分子结构。利用PCR技术直接研究T淋巴细胞,无需细胞培养。使用经过实验验证的Vβ亚家族特异性引物来评估TIL和对照样本中的Vβ使用情况。我们的结果显示,由其V-D-J连接序列精确定义的克隆性T细胞群体在肿瘤部位被扩增。这种局部抗原驱动选择的存在支持了抗肿瘤反应确实可能在消退性黑色素瘤中发生的假说。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f1/288075/77e5e43b1f71/jcinvest00038-0453-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f1/288075/57387e93f1a6/jcinvest00038-0452-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f1/288075/aaf7e1afab79/jcinvest00038-0452-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f1/288075/0f21a49d266a/jcinvest00038-0453-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f1/288075/77e5e43b1f71/jcinvest00038-0453-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f1/288075/57387e93f1a6/jcinvest00038-0452-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f1/288075/aaf7e1afab79/jcinvest00038-0452-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f1/288075/0f21a49d266a/jcinvest00038-0453-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f1/288075/77e5e43b1f71/jcinvest00038-0453-b.jpg

相似文献

1
Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.人类消退性黑色素瘤肿瘤浸润淋巴细胞中T细胞受体变异性分析。原位T细胞克隆性扩增的证据。
J Clin Invest. 1993 Mar;91(3):1183-90. doi: 10.1172/JCI116278.
2
Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.原发性和转移性黑色素瘤肿瘤浸润淋巴细胞中T细胞受体αβ变异性分析
Arch Immunol Ther Exp (Warsz). 1995;43(2):123-33.
3
Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma.原发性人类恶性黑色素瘤消退和进展区域肿瘤浸润淋巴细胞中的克隆性T细胞反应。
J Clin Invest. 1996 Jul 15;98(2):279-84. doi: 10.1172/JCI118790.
4
Analysis of T-cell receptor alpha/beta variability in lymphocytes infiltrating a melanoma metastasis.对浸润黑色素瘤转移灶的淋巴细胞中T细胞受体α/β变异性的分析。
Cancer Res. 1992 Sep 1;52(17):4649-54.
5
Direct evidence to support the immunosurveillance concept in a human regressive melanoma.支持人类消退性黑色素瘤免疫监视概念的直接证据。
J Clin Invest. 1994 Apr;93(4):1397-402. doi: 10.1172/JCI117116.
6
T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.匹配的MART-1肽刺激的外周血淋巴细胞和肿瘤浸润淋巴细胞中的T细胞受体库
Cancer Res. 1997 Dec 1;57(23):5320-7.
7
Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck.头颈部鳞状细胞癌患者T细胞克隆性扩增的证据。
Cancer Res. 1994 Mar 1;54(5):1292-7.
8
Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.肾细胞癌转移灶对自体肿瘤细胞疫苗接种及体外致敏的疫苗引流淋巴结淋巴细胞转移产生寡克隆T细胞应答的证据。
Cancer Res. 1993 Oct 15;53(20):4745-9.
9
Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma.在一例人类消退性黑色素瘤中具有抗肿瘤活性的细胞毒性T淋巴细胞原位扩增的证据。
Cancer Res. 1993 Aug 1;53(15):3569-73.
10
T-cell receptor repertoire of lymphocytes infiltrating cutaneous melanoma is predominated by V alpha specificities present in T-cells of normal human skin.浸润皮肤黑色素瘤的淋巴细胞的T细胞受体库以正常人皮肤T细胞中存在的Vα特异性为主。
Cancer Res. 1994 Sep 1;54(17):4734-9.

引用本文的文献

1
T cell receptor and B cell receptor exhibit unique signatures in tumor and adjacent non-tumor tissues of hepatocellular carcinoma.T 细胞受体和 B 细胞受体在肝癌肿瘤组织和相邻非肿瘤组织中表现出独特的特征。
Front Immunol. 2023 May 29;14:1161417. doi: 10.3389/fimmu.2023.1161417. eCollection 2023.
2
Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells.人血液中次黄嘌呤鸟嘌呤磷酸核糖转移酶突变 T 细胞的分子特征:免疫相关细胞替代选择的概念。
Mutat Res Rev Mutat Res. 2022 Jan-Jun;789:108414. doi: 10.1016/j.mrrev.2022.108414. Epub 2022 Mar 11.
3

本文引用的文献

1
Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells.单克隆抗体653.40S识别的人黑素瘤细胞抗原的结构特性与组织分布
J Natl Cancer Inst. 1981 Sep;67(3):591-601.
2
Prognosis in patients with thin malignant melanoma: influence of regression.薄型恶性黑色素瘤患者的预后:消退的影响
Histopathology. 1983 Sep;7(5):673-80. doi: 10.1111/j.1365-2559.1983.tb02279.x.
3
In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.皮肤原发性恶性黑色素瘤中单核细胞浸润的原位分析。
Single-cell transcriptomics reveal the intratumoral landscape of infiltrated T-cell subpopulations in oral squamous cell carcinoma.
单细胞转录组学揭示了口腔鳞状细胞癌浸润 T 细胞亚群的肿瘤内景观。
Mol Oncol. 2021 Apr;15(4):866-886. doi: 10.1002/1878-0261.12910. Epub 2021 Mar 9.
4
Normalization Cancer Immunotherapy for Melanoma.规范化癌症免疫疗法治疗黑色素瘤。
J Invest Dermatol. 2020 Jun;140(6):1134-1142. doi: 10.1016/j.jid.2020.02.005. Epub 2020 Feb 22.
5
Current Strategies to Enhance Anti-Tumour Immunity.增强抗肿瘤免疫力的当前策略。
Biomedicines. 2018 Mar 23;6(2):37. doi: 10.3390/biomedicines6020037.
6
The signature of liver cancer in immune cells DNA methylation.肝癌在免疫细胞 DNA 甲基化中的特征。
Clin Epigenetics. 2018 Jan 18;10:8. doi: 10.1186/s13148-017-0436-1. eCollection 2018.
7
T Cell Receptor Profiling in Type 1 Diabetes.1型糖尿病中的T细胞受体分析
Curr Diab Rep. 2017 Oct 11;17(11):118. doi: 10.1007/s11892-017-0946-4.
8
Tuning cancer fate: the unremitting role of host immunity.调控癌症转归:宿主免疫的不懈作用
Open Biol. 2017 Apr;7(4). doi: 10.1098/rsob.170006.
9
NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution.转移性黑色素瘤患者中的NKp30异构体和NKp46转录本:罕见的病情进展良好的黑色素瘤患者中独特的NKp30模式
Oncoimmunology. 2016 Mar 10;5(12):e1154251. doi: 10.1080/2162402X.2016.1154251. eCollection 2016.
10
Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病中白血病细胞与宿主免疫细胞的共同进化
Cold Spring Harb Perspect Med. 2017 Apr 3;7(4):a026740. doi: 10.1101/cshperspect.a026740.
Clin Exp Immunol. 1983 Jan;51(1):77-82.
4
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).使用碱性磷酸酶与单克隆抗碱性磷酸酶的免疫复合物(碱性磷酸酶抗碱性磷酸酶复合物,APAAP复合物)对单克隆抗体进行免疫酶标记。
J Histochem Cytochem. 1984 Feb;32(2):219-29. doi: 10.1177/32.2.6198355.
5
Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex.参与抗原特异性人类T细胞功能的克隆型结构。与T3分子复合物的关系。
J Exp Med. 1983 Feb 1;157(2):705-19. doi: 10.1084/jem.157.2.705.
6
Spontaneous regression of primary malignant melanomas with regional metastases.伴有区域转移的原发性恶性黑色素瘤的自发消退。
Cancer. 1965 Nov;18(11):1399-415. doi: 10.1002/1097-0142(196511)18:11<1399::aid-cncr2820181104>3.0.co;2-r.
7
Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.厚度、横截面积及浸润深度在皮肤黑色素瘤预后中的作用
Ann Surg. 1970 Nov;172(5):902-8. doi: 10.1097/00000658-197011000-00017.
8
Immunochemical proof that a novel rearranging gene encodes the T cell receptor delta subunit.免疫化学证据表明,一个新的重排基因编码T细胞受体δ亚基。
Science. 1987 Oct 30;238(4827):682-4. doi: 10.1126/science.3672118.
9
Thin malignant melanomas with regression and metastases.伴有消退和转移的薄型恶性黑色素瘤。
Arch Dermatol. 1987 Oct;123(10):1326-30.
10
Production of stable cytolytic T-cell clones directed against autologous human melanoma.针对自体人黑色素瘤的稳定细胞溶解性T细胞克隆的产生。
Int J Cancer. 1987 Mar 15;39(3):390-6. doi: 10.1002/ijc.2910390320.